Publications by authors named "Susan Holbeck"

Claim this Profile
P
Predicting tumor cell line response to drug pairs with deep learning.
Fangfang Xia, Maulik Shukla, Thomas Brettin, Cristina Garcia-Cardona, Judith Cohn, Susan L Holbeck

BMC Bioinformatics· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay.
Jiuping Ji, Yiping Zhang, Christophe E Redon, William C Reinhold, Alice P Chen, Susan L Holbeck

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity.
Susan L Holbeck, Richard Camalier, James A Crowell, Jeevan Prasaad Govindharajulu, Melinda Hollingshead

Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies.
Melinda G Hollingshead, Luke H Stockwin, Sergio Y Alcoser, Dianne L Newton, Benjamin C Orsburn, Susan L Holbeck

BMC Genomics· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.
Ogan D Abaan, Eric C Polley, Sean R Davis, Yuelin J Zhu, Sven Bilke, Susan L Holbeck

Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel.
James H Doroshow, Agnes Juhasz, Yun Ge, Susan Holbeck, Jiamo Lu

Biochem Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.
Arti B Gaur, Susan L Holbeck, Nancy H Colburn, Mark A Israel

Neuro Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements.
Shivanni Kummar, Helen X Chen, John Wright, Susan Holbeck, Myrtle Davis Millin

Nat Rev Drug Discov· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.
Susan Holbeck, Jianjun Chang, Anne M Best, Angie L Bookout, David J Mangelsdorf

Mol Endocrinol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines.
Susan L Holbeck, Jerry M Collins, James H Doroshow

Mol Cancer Ther· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.
John F Deeken, Robert W Robey, Suneet Shukla, Kenneth Steadman, Arup R Chakraborty, Susan Holbeck

Mol Pharmacol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
Andrew Evans, Victoria Bates, Helen Troy, Stephen Hewitt, Susan Holbeck

Cancer Chemother Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage.
V Ashutosh Rao, Keli Agama, Susan Holbeck, Yves Pommier

Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop.
Angelika B Kritz, Campbell G Nicol, Kate L Dishart, Ruth Nelson, Susan Holbeck

Mol Ther· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity.
Smitha Antony, Keli K Agama, Ze-Hong Miao, Melinda Hollingshead, Susan L Holbeck

Mol Pharmacol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.
Grégoire P Prévost, Marie O Lonchampt, Susan Holbeck, Samir Attoub, Daniel Zaharevitz

Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.
Gurmeet Kaur, Melinda Hollingshead, Susan Holbeck, Vesna Schauer-Vukasinović, Richard F Camalier

Biochem J· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum of activity and molecular correlates of response to phosphatidylinositol ether lipid analogues, novel lipid-based inhibitors of Akt.
Joell J Gills, Susan Holbeck, Melinda Hollingshead, Stephen M Hewitt, Alan P Kozikowski

Mol Cancer Ther· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines.
David B Whyte, Susan L Holbeck

Biochem Biophys Res Commun· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries.
Mikhail G Kolonin, Laura Bover, Jessica Sun, Amado J Zurita, Kim-Anh Do, Susan L Holbeck

Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA class I and II genotype of the NCI-60 cell lines.
Sharon Adams, Fu-Meei Robbins, Deborah Chen, Devika Wagage, Susan L Holbeck

J Transl Med· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicities of three rebeccamycin derivatives in the National Cancer Institute screening of 60 human tumor cell lines.
Pascale Moreau, Susan Holbeck, Michelle Prudhomme, Edward A Sausville

Anticancer Drugs· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription profiling of gene expression in drug discovery and development: the NCI experience.
Edward A Sausville, Susan L Holbeck

Eur J Cancer· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel.
Phyllis A Svingen, David Loegering, Joe Rodriquez, Xue Wei Meng, Peter W Mesner, Susan Holbeck

Clin Cancer Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
Susan D Mertins, Timothy G Myers, Susan L Holbeck, Wilma Medina-Perez, Elaine Wang

Mol Cancer Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis